Talk:Clozapine: Difference between revisions
>Corticosteroid m Added to tox&harm potential. The addition is about neuroleptic malignant syndrome, a dangerous condition that can be caused by antipsychotics like clozapine. |
>Unity Remove overly prescriptive language. Please use do not use second person pronouns ('you should', etc.). The dispensing guideline image is also unnecessary as it is designed for medical practitioners. Cite flag added. |
||
Line 64: | Line 64: | ||
==Toxicity and harm potential== | ==Toxicity and harm potential== | ||
Clozapine | Clozapine is associated with a rare but potentially fatal effect called agranulocytosis (dangerously low white blood cell count).<ref>Mebanga Ojong and Shari N. Allen (2013) Management and prevention of agranulocytosis in patients receiving clozapine. Mental Health Clinician: September 2013, Vol. 3, No. 3, pp. 139-143. https://doi.org/10.9740/mhc.n166825</ref> Therefore lower doses and self-monitoring for this condition are encouraged if taken outside of supervised medical context. | ||
Clozapine can also cause NMS, or neuroleptic malignant syndrome. This reaction is rare, but serious and includes dysfunctions such as muscle rigidity, hyperthermia, paleness, psychomotor agitation, respiratory distress (tachypnea), among others.{{citation needed}} | |||
==Legality== | ==Legality== | ||
{{LegalStub}} | {{LegalStub}} |